Art

J-GLOBAL ID：200902228541256027   Reference number：07A0827547

高脂血症治療薬【EPA製剤の薬理作用とエビデンス】-JELIS(The Japan EPA Lipid Intervention Study)から学ぶもの-

Author (1)： ISHIKAWA YUICHI (神戸大 医 保健学科)
Material： 月刊細胞  (細胞)
Volume： 39  Issue： 10  Page： 427-430  Publication year： Sep. 20, 2007 
JST Material Number： F0692A  ISSN： 1346-7557  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *hypolipidemic drug ,...
Semi thesaurus term： *coronary insufficiency ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0827547&from=J-GLOBAL&jstjournalNo=F0692A") }}

JST classification (1)： Clinical application of drugs acting on lipid metabolism  (GW13050X)

Substance index (1)： Eicosapentaenoic Acid

Reference (11)：

• Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM.: Effects of changes in fat, fish, and fibre intake on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet Sep 30; 2(8666): 759-761, 1989.
• GISSI-Prevenzione investigators: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354: 447-455, 1999.
• Yzebe D, Lievre M.: Fish oil in the care of coronary heart disease patients: a meta-analysis of randomized controlled trials. Fundam. CIin. Pharmacol.18: 581-592, 2004.
• Studer M, Briel M, Leimenstoll B, Glass TR, Bucher HC.: Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med.165: 725-730, 2005.
• Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H. Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; Japan EPA lipid intervention study (JELIS) Investigators.: Effects of eicosapentaenoic acid on major coronary events in hypercholcsterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet.369(9567): 1090-1098, 2007.

Terms in the title (6)： 高脂血症治療薬 ,  EPA ,  製剤 ,  薬理作用 ,  エビデンス ,  JELIS